Company profile: Lazarus Effect
1.1 - Company Overview
Company description
- Provider of novel interventional medical devices to facilitate removal of blood clots, developing a complete portfolio of vascular-device products based on a patented wire-frame technology platform; based in Campbell, California.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Lazarus Effect
ElectroCore
HQ: United States
Website
- Description: Provider of neuromodulation therapies for the non-invasive treatment of diseases and disorders, including gammaCore and gammaCore Sapphire devices offering non-invasive vagus nerve stimulation for migraine and cluster headache treatment; Truvaga, a natural solution designed to enhance mental clarity and overall health; and TAC-STIM, a portable device aimed at the military for vagus nerve stimulation with quick administration and long-lasting benefits.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ElectroCore company profile →
ReNeuron
HQ: United Kingdom
Website
- Description: Provider of stem cell-based exosome technologies and cell therapy programs. Offers the CustomEx platform for customizable exosomes delivering nucleic acids, proteins and gene editing; a conditionally immortalized iPSC platform for allogeneic cell lines and exosome production with specific tissue targeting; and hRPC for retinitis pigmentosa and CTX for stroke-induced disabilities, available for out-license outside of China.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ReNeuron company profile →
Cannevert Therapeutics
HQ: Canada
Website
- Description: Provider of biopharma research and practical applications of cannabis in therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cannevert Therapeutics company profile →
Liftware
HQ: United States
Website
- Description: Provider of electronic stabilizing and leveling utensil handles with interchangeable attachments (soup spoon, everyday spoon, fork, spork), designed to help people eat more easily by reducing utensil shaking for hand tremor and keeping utensils level for limited hand or arm mobility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Liftware company profile →
Inscopix
HQ: United States
Website
- Description: Provider of neural activity imaging solutions for freely behaving subjects, enabling links between circuit dynamics and behavior. Offers the nVue dual-color system with expanded storage for longitudinal studies, the LScape module for wider field of view and longer working distance in cortical imaging, and Multicolor Data Processing software for streamlined miniscope analysis with PCA/ICA or CNMFe, filtering, and longitudinal registration.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Inscopix company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Lazarus Effect
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Lazarus Effect
2.2 - Growth funds investing in similar companies to Lazarus Effect
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Lazarus Effect
4.2 - Public trading comparable groups for Lazarus Effect
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →